Health care startups that raised Series B in Zhejiang, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| RoboCT | Yuhang | Series B | $14.5M | 2026-03-04 |
| Xinzeyuan Medical | Hangzhou | Series B | $10.2M | 2025-01-20 |
| Laifu Technology | Hangzhou | Series B | $13.8M | 2024-06-03 |
| Hengyu Biotechnology | Jiaxing | Series B | $27.8M | 2024-03-11 |
| Linstant | Ningbo | Series B | $14.1M | 2024-01-08 |
| Chuangjian Medical | Changzhou | Series B | $27.5M | 2023-09-16 |
| Qihan Biotech | Hangzhou | Series B | $16.0M | 2023-09-15 |
| Aorui Bio | Hangzhou | Series B | $13.7M | 2023-09-11 |
8 rows of the CSV in 5 of its 18 columns.
- The 75 health care startups in Zhejiang, China whose last round is Series B have raised $2.2B in total.
- 11 of them closed their most recent round in the last 12 months, $130.9M combined.
- The largest of those rounds is Imbioray's $28.8M Series B, dated February 2026.
- The most recent is Rhino Medical's $15.0M Series B on 6 November 2026.
- Fortune Venture Capital is an investor in 3 of them, more than any other fund.
- Biotech is the most common other sector, with 27 companies (36%).
- 13% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (41% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 75| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| RoboCT | RoboCT develops exoskeleton robots that help patients with lower-body motor dysfunction learn to walk. | Artificial intelligence | Yuhang | Series B | $14.5M | 2026-03-04 | $47.3M | Fortune Venture Capital, Poly Capital, Pappas Capital | 51 to 100 | 2017 |
| Hengyu Biotechnology | Hengyu Biotechnology provides biosafety testing and process validation through a CXO platform. | Biotech | Jiaxing | Series B | $27.8M | 2024-03-11 | CMB International Capital Corporation, GP Capital, Haibang Capital +2 | 101 to 250 | 2020 | |
| Linstant | Linstant supplies medical device accessories and offers tailored one-to-one solutions. | Health care | Ningbo | Series B | $14.1M | 2024-01-08 | $14.1M | Haibon fenghua VC | 101 to 250 | 2014 |
| Chuangjian Medical | Chuangjian Medical Technology develops, sells, and researches novel protein and nucleic acid-based medicines. | Biotech | Changzhou | Series B | $27.5M | 2023-09-16 | $57.2M | CDH Investments, L Catterton, CDF-Capital +1 | 101 to 250 | 2015 |
| Qihan Biotech | Qihan Biotech develops gene-editing technology for organ transplantation. | Biotech | Hangzhou | Series B | $16.0M | 2023-09-15 | $116.3M | Matrix Partners China, Northern Light Venture Capital, CMB International Capital Corporation +1 | 101 to 250 | 2017 |
Table 1. Health care startups that raised Series B in Zhejiang, China: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RoboCT | RoboCT develops exoskeleton robots that help patients with lower-body motor dysfunction learn to walk. | Artificial intelligence | Yuhang | Series B | $14.5M | 2026-03-04 | $47.3M | Fortune Venture Capital, Poly Capital, Pappas Capital | 51 to 100 | 2017 |
Table 2. Health care startups that raised Series B in Zhejiang, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 3 | 4% | 1 | RoboCT |
| 2 | Yinxinggu Capital | Venture capital firm | Hangzhou, China | 3 | 4% | ||
| 3 | CMB International Capital Corporation | Investment bank | Central, Hong Kong | 2 | 3% | ||
| 4 | Source Code Capital | Venture capital firm | Chaoyang, China | 2 | 3% | ||
| 5 | Puhua Capital | Venture capital firm | Hangzhou, China | 2 | 3% | ||
| 6 | Poly Capital | Private equity firm | Guangzhou, China | 1 | 1% | 1 | RoboCT |
| 7 | Pappas Capital | Venture capital firm | Durham, United States | 1 | 1% | 1 | RoboCT |
| 8 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 9 | Dianshi Zichan | Private equity firm | Shanghai, China | 1 | 1% | ||
| 10 | Jinding Capital | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 11 | Korea Investment Partners | Private equity firm | Seoul, South Korea | 1 | 1% | ||
| 12 | Blue Bay Ventures | Venture capital firm | California City, United States | 1 | 1% | ||
| 13 | Cowin Capital | Private equity firm | Shenzhen, China | 1 | 1% | ||
| 14 | Hongda Capital | Venture capital firm | Shanghai, China | 1 | 1% | ||
| 15 | Lucky Source Funds | Private equity firm | Shenzhen, China | 1 | 1% |
Table 3. Health care startups that raised Series B in Zhejiang, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 27 | 36% | $475.6M |
| Software | 10 | 13% | $327.3M |
| Artificial intelligence | 8 | 11% | $206.1M |
| Hardware | 6 | 8% | $123.3M |
| Commerce | 4 | 5% | $29.8M |
Table 4. Health care startups that raised Series B in Zhejiang, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 75 | 100% | $14.5M |
Table 5. Health care startups that raised Series B in Zhejiang, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Hangzhou | 55 | 73% |
| Changzhou | 6 | 8% |
| Jiaxing | 3 | 4% |
| Shaoxing | 3 | 4% |
| Ningbo | 2 | 3% |
| Yuhang | 1 | 1% |
| Cheng | 1 | 1% |
| Jiangdu | 1 | 1% |
| Huzhou | 1 | 1% |
| Jiaojiang | 1 | 1% |
| Xiaoshan | 1 | 1% |
Table 6. Health care startups that raised Series B in Zhejiang, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 18% | $30.0M |
| September 2026 | 1 | 9% | $14.9M |
| June 2026 | 1 | 9% | |
| May 2026 | 1 | 9% | $14.4M |
| March 2026 | 1 | 9% | $14.5M |
| February 2026 | 1 | 9% | $28.8M |
| December 2025 | 2 | 18% | $14.3M |
| November 2025 | 2 | 18% | $14.1M |
Table 7. Health care startups that raised Series B in Zhejiang, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 9% | $102.5M |
| 2025 | 10 | 13% | $122.5M |
| 2024 | 7 | 9% | $83.5M |
| 2023 | 13 | 17% | $100.6M |
| 2022 | 9 | 12% | $74.3M |
| 2021 | 8 | 11% | $313.0M |
Table 8. Health care startups that raised Series B in Zhejiang, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 10 | 13% |
| 2015 to 2019 | 34 | 45% |
| 2010 to 2014 | 22 | 29% |
| Before 2010 | 9 | 12% |
Table 9. Health care startups that raised Series B in Zhejiang, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 6 | 9% |
| 11 to 50 | 26 | 41% |
| 51 to 100 | 8 | 12% |
| 101 to 250 | 12 | 19% |
| 251 to 500 | 6 | 9% |
| 501 to 1,000 | 4 | 6% |
| 1,001 to 5,000 | 2 | 3% |
Table 10. Health care startups that raised Series B in Zhejiang, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Zhejiang, China. On 16 November 2026 that is 75 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 75 rows: 28 have no round amount, 0 no city and 27 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Zhejiang, China whose last round is Series B are on the list?
- 75, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.